This inventor holds 3 USPTO granted patents. Top assignee: Southern Research Institute. Active years: 1994-2003.
Location History:
- Vastra Frolunda, SE (1994 - 2003)
- Birmingham, AL (US) (2003)
Company Filing History:
Years Active: 1994-2003
Title: Amanda McRae-McFarlane: Innovator in Neuroactive Agent Delivery
Introduction
Amanda McRae-McFarlane is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of drug delivery systems, particularly in the area of neuroactive agents. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
One of her latest patents focuses on microcapsules for the administration of neuroactive agents. This invention relates to polymeric microspheres that serve as injectable drug-delivery vehicles. These microspheres are designed to deliver bioactive agents to specific sites within the central nervous system. Additionally, they stimulate nerve fiber growth by implanting these microspheres within the central nervous system of a patient. The invention emphasizes the use of microspheres with a mean diameter of less than 45 µm, preferably less than about 20 µm, and ideally between 0.1 µm to about 10 µm. These microspheres are selectively taken up by astrocytes when delivered directly into nervous tissues.
Career Highlights
Amanda is currently employed at Southern Research Institute, where she continues to innovate and develop new technologies. Her work is instrumental in advancing the understanding and treatment of neurological conditions.
Collaborations
Some of her notable coworkers include Thomas R. Tice and Deborah L. Dillon, who contribute to her research efforts and collaborative projects.
Conclusion
Amanda McRae-McFarlane is a trailblazer in the field of neuroactive agent delivery, with her innovative patents and contributions to medical science. Her work at Southern Research Institute exemplifies her commitment to improving healthcare through technology.